Abstract
Adenosine is a neuromodulator mostly acting through A1(inhibitory) and A2A(excitatory) receptors in the brain. A2Breceptors (A2BR) are Gs/q‐protein‐coupled receptors with low expression in the brain. As A2BRfunction is largely unknown, we have now explored their role in the mouse hippocampus. We performed electrophysiological extracellular recordings in mouse hippocampal slices, and immunological analysis of nerve terminals and glutamate release in hippocampal slices and synaptosomes. Additionally, A2BR‐knockout (A2BR‐KO) and C57/BL6 mice were submitted to a behavioural test battery (open field, elevated plus‐maze, Y‐maze). The A2BRagonistBAY60‐6583 (300 nm) decreased the paired‐pulse stimulation ratio, an effect prevented by the A2BRantagonistMRS 1754 (200nM) and abrogated in A2BR‐KOmice. Accordingly, A2BRimmunoreactivity was present in 73 ± 5% of glutamatergic nerve terminals, i.e. those immunopositive for vesicular glutamate transporters. Furthermore,BAY 60‐6583 attenuated the A1R control of synaptic transmission, both the A1R inhibition caused by 2‐chloroadenosine (0.1–1 μm) and the disinhibition caused by the A1R antagonistDPCPX(100 nm), both effects prevented byMRS 1754 and abrogated in A2BR‐KOmice.BAY 60‐6583 decreased glutamate release in slices and also attenuated the A1R inhibition (CPA100 nm). A2BR‐KOmice displayed a modified exploratory behaviour with an increased time in the central areas of the open field, elevated plus‐maze and the Y‐maze and no alteration of locomotion, anxiety or working memory. We conclude that A2BRare present in hippocampal glutamatergic terminals where they counteract the predominant A1R‐mediated inhibition of synaptic transmission, impacting on exploratory behaviour.

This publication has 81 references indexed in Scilit: